HEXO Hydropothecary Corp

HEXO Corp provides corporate update

HEXO Corp provides corporate update

OTTAWA, Feb. 07, 2020 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) wishes to announce two corporate developments. HEXO has changed its auditor from MNP LLP to PricewaterhouseCoopers LLP effective January 31, 2020. In addition, Nathalie Bourque is resigning from HEXO’s Board of Directors, effective today.

HEXO has changed its auditor from MNP LLP to PricewaterhouseCoopers LLP. The resignation of MNP LLP and the appointment of PricewaterhouseCoopers LLP have been considered and approved by the Company’s Audit Committee and Board of Directors. In accordance with the requirements of National Instrument 51-102 - Continuous Disclosure Obligations, a change of auditor notice and related materials have been filed under HEXO’s profile on SEDAR. There were no “reportable events” (within the meaning of National Instrument 51-102) involving MNP LLP.

Nathalie Bourque is resigning from HEXO’s Board of Directors, effective today.

“I would like to take this opportunity to thank Nathalie Bourque for over two years of service on HEXO’s Board of Directors,” said HEXO CEO and co-founder Sebastien St-Louis. “Nathalie’s extensive experience in communications, public affairs and investor relations across financial, biopharmaceutical, retail and entertainment industries were an invaluable contribution to HEXO as we entered the legal adult-use market and grew exponentially.”

About HEXO

HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. Through its hub and spoke business strategy, HEXO Corp is partnering with Fortune 500 companies, bringing its brand value, cannabinoid isolation technology, licensed infrastructure and regulatory expertise to established companies, leveraging their distribution networks and capacity. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis. For more information please visit hexocorp.com.  ‎

Investor Relations:

Jennifer Smith

1-866-438-8429



Media Relations:

(819) 317-0526

EN
07/02/2020

Underlying

HEXOHydropothecary Corp

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Hydropothecary Corp

 PRESS RELEASE
Free
HEXO Hydropothecary ...

HEXO publie ses résultats financiers du 1T2023

HEXO publie ses résultats financiers du 1T2023 Le présent communiqué de presse constitue un « communiqué de presse désigné » aux fins du supplément de prospectus de la Société daté du 2 mai 2022 à son prospectus préalable de base simplifié daté du 7 mai 2021 et modifié et mis à jour le 25 mai 2021 Le réalignement stratégique a produit d’importants résultats dans l’ensemble de l’entreprise, y compris des améliorations d’un trimestre à l’autre du BAIIA ajusté et une augmentation de la marge brute avant rajustements.HEXO a signé de nouveaux contrats de culture et éliminé des ventes non rentab...

December 15, 2022 1 EN
 PRESS RELEASE
Free
HEXO Hydropothecary ...

HEXO Reports Q1’23 Financial Results

HEXO Reports Q1’23 Financial Results This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021. Strategic realignment demonstrates significant results across the business, including quarter over quarter improvements to Adjusted EBITDA and increased gross margin before adjustmentsHEXO has signed new cultivation agreements and purged unprofitable salesRedecan brand achieved record sales, prompting 300% increase in produ...

December 15, 2022 1 EN
 PRESS RELEASE
Free
HEXO Hydropothecary ...

HEXO Corp. annonce le regroupement de ses actions

HEXO Corp. annonce le regroupement de ses actions GATINEAU, Québec, 14 déc. 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX : HEXO; NASDAQ : HEXO) (« HEXO » ou la « Société »), chef de file dans la production de produits du cannabis de haute qualité, a annoncé aujourd'hui qu’à la suite de l’approbation par les actionnaires d’un regroupement des actions ordinaires de la Société (les « actions ordinaires ») selon une fourchette de deux (2) à quatorze (14) actions ordinaires existantes préregroupement contre une (1) action ordinaire postregroupement (le « regroupement ») lors de l’assemblée annuell...

December 14, 2022 1 EN
 PRESS RELEASE
Free
HEXO Hydropothecary ...

HEXO Corp Announces Share Consolidation

HEXO Corp Announces Share Consolidation GATINEAU, Quebec, Dec. 14, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company”), a leading producer of high-quality cannabis products, today announced that, following shareholder approval of a consolidation of the common shares of the Company (“Common ‎Shares”) on the basis of a range between two (2) and fourteen (14) existing pre-consolidation Common ‎Shares for every one (1) post-consolidation Common Share (the “Consolidation”) at the annual and special meeting of the shareholders of the Company held on March 8, ...

December 14, 2022 1 EN
 PRESS RELEASE
Free
HEXO Hydropothecary ...

HEXO Corp Announces Repayment of 8.0% Unsecured Convertible Debentures

HEXO Corp Announces Repayment of 8.0% Unsecured Convertible Debentures Repayment strengthens HEXO’s balance sheet and positions it for sustainable growth This news release constitutes a “designated news release” for the purposes of HEXO’s prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021. GATINEAU, Quebec, Dec. 06, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company”), a leading producer of high-quality cannabis products, today announced that it has repaid the tota...

December 6, 2022 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch